跳至主要内容
临床试验/NCT06620094
NCT06620094已完成不适用

The EFFECT of MOBILE APPLICATION USE on DIABETES CONTROL in DIABETIC PATIENTS

Inonu University1 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2021年5月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
38
试验地点
1
主要终点
A1C levels

研究概览

简要总结

Objective:This study aims to determine the effect of a mobile application on diabetes control in patients with Type 2 diabetes.

Methods:This study is a randomized controlled trial with a pre-test and post-test design. The study population consists of Type 2 diabetes patients who applied to the Endocrinology Clinic of Malatya Turgut Özal Medical Center. A total of 70 participants were included in the study. Data were collected face-to-face using a demographic data collection form, a diabetes diagnosis and follow-up form, and the Turkish Multidimensional Diabetes Scale. The data were analyzed using paired t-tests and independent samples t-tests to compare means, counts, and percentages in dependent and independent groups.

详细描述

Type of Study: This study is a pre-test, post-test randomized controlled experimental study.

Population and Sample of the Study: The population of the study consisted of individuals with type 2 diabetes who applied to the Endocrinology Clinic of Malatya Inonu University Turgut Ozal Medical Center between May 2021 and December 2021. The sample included patients who met the inclusion criteria during the dates of the study and who applied to the Endocrinology Clinic. The power analysis used to determine the sample size was calculated with a 5% margin of error, 95% confidence interval at a two-sided significance level, and 80% population representation capacity, with 50 diabetic individuals for each group (50 experimental, 50 control). However, the study was completed with 38 individuals in the experimental group and 32 in the control group.

Inclusion Criteria:

Having been diagnosed with type 2 diabetes mellitus for at least 6 months. Being between the ages of 40-65. Receiving oral antidiabetic treatment. Having an A1C value between 7%-10%. Owning a mobile phone capable of receiving and playing video messages. Not having sensory impairments, such as hearing or speech loss, or psychiatric problems that prevent communication.

Exclusion Criteria:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
35 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Having been diagnosed with type 2 diabetes mellitus for at least 6 months. Being between the ages of 40-
  • •Receiving oral antidiabetic treatment. Having an A1C value between 7%-10%. Owning a mobile phone capable of receiving and playing video messages. Not having sensory impairments, such as hearing or speech loss, or psychiatric problems that prevent communication.

排除标准

  • •Inability to use the mobile application. Patients with a psychological diagnosis according to records. Patients using insulin. Having an A1C value above 10%. Having an infection requiring medication.

研究组 & 干预措施

Intervention Group

Experimental

This group, used mobile application and underwent routine controls.

干预措施: diabetes education videos (Other)

Control Group

No Intervention

This group, underwent only routine controls.

结局指标

主要结局

A1C levels

时间窗: up to seven months

Hemoglobin A1C (HbA1C): HbA1C is a blood test that measures the average blood glucose levels over the past two to three months by determining the percentage of glycated hemoglobin in the blood. It is commonly used to diagnose diabetes and assess the effectiveness of diabetes management. An HbA1C level below 5.7% is considered normal, between 5.7% and 6.4% indicates prediabetes, and a level of 6.5% or higher indicates diabetes.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Fidan Balkaya

Research Asistant

Inonu University

研究点 (1)

Loading locations...

相似试验